Institutional Ownership Prime Medicine, Inc. (PRME)
This table provides information about the institutional ownership of Prime Medicine, Inc. (PRME). We have compiled data on the 123 institutions that hold shares in the stock, with a total of 64.7 Million shares, which have been reported (via 13F filing form) to have a value of $188 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Alphabet Inc.
Mountain View, CA |
Nov 07, 2024 Q3 2024 |
15,062,498
shares
|
$43.7 Million
3.99% of portfolio
|
Q1 2024
Added 26.98%
|
|
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
Oct 31, 2024 Q3 2024 |
5,660,719
shares
|
$16.4 Million
0.21% of portfolio
|
Q3 2024
Reduced 7.61%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,110,418
shares
|
$14.8 Million
0.0% of portfolio
|
Q2 2024
Added 36.05%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
4,890,313
shares
|
$14.2 Million
0.0% of portfolio
|
Q3 2024
Reduced 19.55%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
3,807,287
shares
|
$11 Million
0.01% of portfolio
|
Q3 2024
Added 2.19%
|
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Nov 05, 2024 Q3 2024 |
3,190,455
shares
|
$9.25 Million
0.01% of portfolio
|
Q3 2024
Reduced 1.48%
|
|
|
Nikko Asset Management Americas, Inc.
|
Nov 07, 2024 Q3 2024 |
3,182,455
shares
|
$9.23 Million
0.14% of portfolio
|
Q3 2024
Reduced 1.73%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
2,198,240
shares
|
$6.37 Million
0.0% of portfolio
|
Q3 2024
Added 65.17%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
2,074,350
shares
|
$6.02 Million
0.52% of portfolio
|
Q1 2024
Added 56.63%
|
|
|
Mwg Management Ltd.
Washington, DC |
Nov 08, 2024 Q3 2024 |
1,792,210
shares
|
$5.2 Million
7.68% of portfolio
|
Q2 2023
Reduced 2.38%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,545,961
shares
|
$4.48 Million
0.0% of portfolio
|
Q2 2024
Reduced 38.72%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,359,979
shares
|
$3.94 Million
0.0% of portfolio
|
Q3 2024
Added 4.89%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,146,949
shares
|
$3.33 Million
0.0% of portfolio
|
Q3 2024
Added 3.9%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,070,000
shares
|
$3.1 Million
0.31% of portfolio
|
Q3 2024
Added 137.78%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,028,466
shares
|
$2.98 Million
0.04% of portfolio
|
Q4 2022
New holding
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
896,960
shares
|
$2.6 Million
0.06% of portfolio
|
Q2 2024
Added 1.32%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
750,000
shares
|
$2.18 Million
0.01% of portfolio
|
Q1 2024
New holding
|
|
|
Greenwich Wealth Management LLC
Greenwich, CT |
Oct 29, 2024 Q3 2024 |
733,001
shares
|
$2.13 Million
0.19% of portfolio
|
Q3 2024
Added 12.25%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
700,000
shares
|
$2.03 Million
0.12% of portfolio
|
Q1 2024
New holding
|
|
|
Avidity Partners Management LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
694,000
shares
|
$2.01 Million
0.16% of portfolio
|
Q2 2024
Reduced 65.13%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
540,304
shares
|
$1.57 Million
1.21% of portfolio
|
Q1 2024
Added 14.88%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
524,548
shares
|
$1.52 Million
0.0% of portfolio
|
Q3 2024
Added 33.3%
|
|
|
Moore Capital Management, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
500,000
shares
|
$1.45 Million
0.04% of portfolio
|
Q1 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
485,125
shares
|
$1.41 Million
0.0% of portfolio
|
Q3 2024
Added 13.51%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
463,977
shares
|
$1.35 Million
0.0% of portfolio
|
Q3 2024
Reduced 5.75%
|